NCT07071376

Brief Summary

The standard dialysate temperature is usually set at 36.5°C in hemodialysis applications. Since this temperature is close to the patient's body temperature, it is ideal for preventing the patient from experiencing hypothermia while ensuring cardiovascular stability. In the literature, it is seen that changing the dialysate temperature, especially cold dialysis applications, is used in the management of nausea, the effect on vital signs, determining hemodialysis adequacy and common complications, and in the management of symptoms such as hypotension, cardiac stability, vascular stability, fatigue, and muscle cramps. However, no study has been found using cold dialysis in the management of fatigue that develops after dialysis.Therefore, the aim of this study is to examine the effect of cold dialysis application on post-dialysis fatigue in patients receiving hemodialysis treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
57

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 15, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2025

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

June 16, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 17, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2025

Completed
Last Updated

April 16, 2026

Status Verified

April 1, 2026

Enrollment Period

1 month

First QC Date

June 16, 2025

Last Update Submit

April 15, 2026

Conditions

Keywords

dialysiscold dialysisfatique

Outcome Measures

Primary Outcomes (1)

  • Post-dialysis fatigue scale

    A minimum score of 11 and a maximum score of 55 is obtained from this scale, and an increase in the score indicates an increase in the severity of fatigue.

    1 week

Secondary Outcomes (1)

  • Thermal comfort perception

    1 week

Study Arms (1)

Cold Dialysis

EXPERIMENTAL

To be applied with cold dialysis

Other: cold dialysis

Interventions

Patients who meet the inclusion criteria will receive 3 sessions of cold dialysis treatment by reducing the dialysate temperature from 36.5°C to 36°C. Patients will receive this treatment for 1 week, i.e. 3 dialysis sessions. Each dialysis session will last 4 hours. During each dialysis session, the thermal comfort status of the patients will be evaluated by applying the numeric visual analog scale (NVAS) at the beginning of dialysis, at the 1st, 2nd, 3rd, 4th hours of dialysis and at the end of dialysis. In addition, the day after each session, the patients will be called by phone and the Postdialysis Fatigue Scale will be re-administered and their fatigue levels will be evaluated.

Cold Dialysis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who agreed to participate in the study
  • Age 18 and over
  • Having been on hemodialysis for at least 6 months
  • Having hemodialysis 3 times a week
  • Having a post-dialysis fatigue score ≥28.

You may not qualify if:

  • Having an active infection
  • Having a body temperature above 37.5°C
  • Having serious cardiovascular diseases (e.g., uncontrolled hypertension, congestive heart failure)
  • Having a history of acute complications during dialysis
  • Having a history of severe hypotension
  • Patients whose dialysis treatment was interrupted

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baskent University

Ankara, Türkiye, 109861, Turkey (Türkiye)

Location

Study Officials

  • Gülay Turgay

    Baskent Universitesi

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Cold dialysis group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant professor

Study Record Dates

First Submitted

June 16, 2025

First Posted

July 17, 2025

Study Start

May 15, 2025

Primary Completion

June 15, 2025

Study Completion

September 15, 2025

Last Updated

April 16, 2026

Record last verified: 2026-04

Locations